Study Reveals Importance Of Timing For Cellular Signals, Suggests Possible Tactic For Cancer Therapeutics
Magic tricks work because they take advantage of the brain’s sensory assumptions, tricking audiences into seeing phantoms or overlooking sleights of hand. Now a team of UC San Francisco researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
“The ability to perceive and respond to the environment is a basic attribute of all living organisms, from the greatest to the smallest,” said Wendell Lim, PhD, the study’s senior author. “And so is the susceptibility to misperception. It doesn’t matter if the illusion is based on molecular sensors within a single cell or neurons in the brain.”
In the new study, published online Nov. 19, 2015 in Science Express, Lim and his team discovered that yeast cells falsely perceive a specifically timed pattern of stress – caused by alternating between low and mildly increased sodium levels – as a massive, continuously increasing ramp of stress. In response, the microbes end up over-responding and killing themselves. The results, Lim says, suggest a whole new way of looking at the perceptual abilities of simple cells and could even be used to develop new approaches to fighting diseases using the power of illusion.
Timing of stress response is yeast cells’ ‘Achilles heel’
“This discovery was a bit of an accident actually,” said Lim, chair of the Department of Cellular and Molecular Pharmacology at UCSF, director of the UCSF Center for Systems and Synthetic Biology, and a Howard Hughes Medical Institute (HHMI) investigator. “We were interested in the general issue of how cells interpret information over time. Frequency is a key aspect of all our communications, whether it’s hearing language or transmitting radio signals, but do cells themselves use this kind of information? It’s something we don’t know much about.”
To explore this question, two postdoctoral fellows in Lim’s lab, Ping Wei, PhD, now at Peking University School of Life Sciences, and Amir Mitchell, PhD, set up a system that allowed them to expose yeast to a mild stressor – a small increase in salt in the yeast’s environment – and to oscillate between the increased salt level and the baseline level at different frequencies.
Normally, sensor molecules in a yeast cell detect changes in salt concentration and instruct the cell to respond by producing a protective chemical. After this transient response, the cell can resume growing happily as if conditions had not changed. The researchers found that the cells were perfectly capable of adapting when they flipped the salt stress on and off every minute or every 32 minutes. But to their surprise, when they tried an eight-minute oscillation of precisely the same salt level the cells quickly stopped growing and began to die off.
“That was just a jaw-dropping moment,” said Mitchell. “These cells should be able to handle this level of osmotic stress, but at one particular frequency they just go haywire. We’d never seen anything like this before.”
Could sensory illusions be used to fight cancer?
Mitchell, who was first author on the new study, went on to inspect the cellular mechanism underlying this unexpected, frequency-dependent toxicity. Using mathematical modeling and experiments in which he tweaked the molecular wiring of the mitogen activated protein kinase (MAPK) pathway that mediates the cells’ salt-sensing system, he revealed a sensory misperception: Because of the way the MAPK pathway is set up, the cells interpret an eight-minute oscillation as an ever-increasing staircase of salt concentration. This leads to excessive activation of the cells’ protective response, and ultimately to their death (see Movie).
The Latest on: Cancer Therapeutics
via Google News
The Latest on: Cancer Therapeutics
- First patient dosed with Sirnaomics’ cancer drug candidateon January 19, 2021 at 10:06 am
Sirnaomics Inc., a Gaithersburg-based biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, Tuesday announced dose ...
- Nurix Therapeutics, Inc.’s Lock-Up Period Set To End Tomorrow (NASDAQ:NRIX)on January 19, 2021 at 9:59 am
Nurix Therapeutics’ (NASDAQ:NRIX) lock-up period will end on Wednesday, January 20th. Nurix Therapeutics had issued 11,000,000 shares in its IPO on July 24th. The total size of the offering was ...
- Starton Therapeutics reimagines existing medicines to fight blood cancer with continuous dosing technologyon January 19, 2021 at 5:24 am
The company develops transdermal (on the skin) and subcutaneous (under the skin) delivery treatments that administer targeted medicines ...
- Lilly to Pay Merus as Much as $1.6 Billion in Cancer Team-Upon January 19, 2021 at 4:00 am
Eli Lilly & Co. will pay Merus NV as much as $1.6 billion to collaborate on research and development of up to three early experimental cancer drugs.
- TCR² Therapeutics Announces Proposed Public Offering of Common Stockon January 19, 2021 at 3:57 am
TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or the “Company”), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for ...
- Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platformon January 18, 2021 at 9:56 pm
Australian biotech company Prescient Therapeutics (ASX:PTX) has announced what’s next for its next-generation gene therapy technology for fighting cancer.
- Colorectal Cancer Diagnostics and Therapeutics Market - Global Growth, Trends, and Forecasts to 2025on January 15, 2021 at 6:08 am
The "Colorectal Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has ...
- Cytovia Therapeutics Partners with National Cancer Institute to Develop Novel Gene-Edited,on January 13, 2021 at 10:52 pm
Cytovia Therapeutics, an emerging biopharmaceutical company focusing on Natural Killer cells in cancer, announced today that it has signed a licensing agreement with the National Cancer Institute (NCI ...
- Pet Cancer Therapeutics Market 2020 Key Dynamics, Recent and Future Demand, Trend, Analysis upto 2027on January 12, 2021 at 6:03 pm
Global " Pet Cancer Therapeutics Market" 2020 report includes the market strategy, market orientation, expertise ...
- Peptide Based Cancer Therapeutics Market Size, Growth, Analysis, Opportunities and Forecast To 2027on January 12, 2021 at 3:58 pm
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 . The report a??Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis ...
via Bing News